Tomoyuki Yamada

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 12

Top Topics

Methicillin Resistant Staphylococcus Aureus

Top Venues

British journal of clinical pharmacology

International journal of clinical pharmacy

Basic & clinical pharmacology & toxicology

Clinical and translational science

This page only lists publications with an associated author ORCID identifier.

Publications

Tomoyuki Yamada, Kazutaka Oda, Masami Nishihara, Masashi Neo
A simulation study on model-informed precision dosing of amikacin for achieving target area under the concentration-time curve. British journal of clinical pharmacology (2024)
Tomoyuki Yamada, Kazutaka Oda, Masami Nishihara, Masashi Neo
A simulation study on model-informed precision dosing of amikacin for achieving target area under the concentration-time curve. British journal of clinical pharmacology 90 (4) (2024)
Tomoyuki Yamada, Kazutaka Oda, Masami Nishihara, Masashi Neo
A simulation study on model-informed precision dosing of amikacin for achieving target area under the concentration-time curve. British journal of clinical pharmacology 90 (4) (2024)
Tomoyuki Yamada, Kazutaka Oda, Masami Nishihara, Masashi Neo
A simulation study on model-informed precision dosing of amikacin for achieving target area under the concentration-time curve. British journal of clinical pharmacology 90 (4) (2024)
Tomoyuki Yamada, Kazutaka Oda, Masami Nishihara, Masashi Neo
A simulation study on model-informed precision dosing of amikacin for achieving target area under the concentration-time curve. British journal of clinical pharmacology 90 (4) (2024)
Tomoyuki Yamada, Kazutaka Oda, Masami Nishihara, Masashi Neo
A simulation study on model-informed precision dosing of amikacin for achieving target area under the concentration-time curve. British journal of clinical pharmacology 90 (4) (2024)
Tomoyuki Yamada, Kazutaka Oda, Masami Nishihara, Masashi Neo
A simulation study on model-informed precision dosing of amikacin for achieving target area under the concentration-time curve. British journal of clinical pharmacology 90 (4) (2024)
Tomoyuki Yamada, Ryuji Kato, Yoshio Ijiri, Masami Nishihara, Masashi Neo
Disproportionality analysis of acetaminophen-induced hepatic disorders with and without immune checkpoint inhibitors. International journal of clinical pharmacy (2023)
Kazutaka Oda, Tomoyuki Yamada, Kazuaki Matsumoto, Yuki Hanai, Takashi Ueda, Masaru Samura, Akari Shigemi, Hirofumi Jono, Hideyuki Saito, Toshimi Kimura
Model-informed precision dosing of vancomycin for rapid achievement of target area under the concentration-time curve: A simulation study. Clinical and translational science (2023)
Tomoyuki Yamada, Satoru Mitsuboshi, Kaoru Suzuki, Masami Nishihara, Masashi Neo
Analysis of the frequency of ceftriaxone-induced encephalopathy using the Japanese Adverse Drug Event Report database. International journal of clinical pharmacy 44 (4) (2022)
Tomoyuki Yamada, Satoru Mitsuboshi, Junko Makino, Kaoru Suzuki, Masami Nishihara, Masashi Neo
Risk of pregabalin-induced hypoglycemia: Analysis of the Japanese Adverse Event Report database. Journal of clinical pharmacology (2021)
Tomoyuki Yamada, Satoru Mitsuboshi, Kaoru Suzuki, Masami Nishihara, Kazuhisa Uchiyama
Risk of muscle toxicity events for daptomycin with and without statins: Analysis of the Japanese Adverse Event Report database. Basic & clinical pharmacology & toxicology 129 (3) (2021)